Journal of the European Academy of Dermatology and Venereology

Papers
(The H4-Index of Journal of the European Academy of Dermatology and Venereology is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Editor's Picks274
Pioneers in Dermatology and Venereology: an Interview with Professor David M. Pariser187
Clinical evaluation of anaesthetic‐like effect of two dermocosmetic formulations containing Aquaphilus dolomiae extract‐G3 in subjects with sensitive facial skin177
Pioneers in Dermatology and Venereology: An Interview with Professor Danilo V. Stevanovic160
Pioneers in Dermatology and Venereology: An Interview with Professor An Goossens155
Are non‐fungible tokens the barrier to realizing the Dermoverse?138
Announcement119
88
Announcement85
Editor's Picks January 202481
Commentary on vitiligo patient population and disease burden in France: VIOLIN Study results from the CONSTANCES cohort77
Announcement74
Peer review, scientific publishing and the law of reciprocity69
Issue Information69
68
Pioneers in Dermatology and Venereology: an interview with Professor Sarolta Kárpáti64
Efficacy of imiquimod in the management of lentigo maligna61
2013–2023: A decade of progress and challenges in dermatology as reflected in JEADV60
Juvenile localized scleroderma: A single‐centre experience from India58
A dermocosmetic product containing the sap of oat plantlets and Garcinia mangostana extract improves the clinical signs of acne58
Angiolymphoid hyperplasia with eosinophilia infiltrated by GATA3+ Th2 cells responding to dupilumab56
54
Comparison of molecular and serological assays on cerebrospinal fluid for the diagnosis of neurosyphilis53
Issue Information52
Announcement50
50
Contact allergy may enhance further sensitization to new chemicals, but individual susceptibility traits are important for polysensitization48
The Eczema Area and Severity Index: An update of progress and challenges in its measurement of atopic dermatitis after 20 years of use48
Announcement47
Dalbavancin for the treatment of severe hidradenitis suppurativa46
A case of eruptive halo nevi following COVID‐1943
Erythema multiforme major associated with molnupiravir treatment for SARS‐CoV‐2 infection: First report43
The chicken or the egg of lymphopenia in atopic eczema43
Genomic and antimicrobial resistance analyses of Neisseria gonorrhoeae isolates, Burkina Faso, 2018–201942
The future of digital pills and their potential use in dermatological clinical trials42
Deep learning predicted perceived age is a reliable approach for analysis of facial ageing: A proof of principle study41
Two cases of anti‐TIF1‐γ antibody positive dermatomyositis with manifested symptoms after SARS‐CoV‐19 vaccination41
Pharmacovigilance: The responsibility of all40
Automated dermatoscopic pattern discovery by clustering neural network output for human–computer interaction40
Flagellate purpura associated with COVID‐19 vaccination40
0.10390710830688